Cargando…
Erythropoiesis In Vitro—A Research and Therapeutic Tool in Thalassemia
Thalassemia (thal) is a hereditary chronic hemolytic anemia due to a partial or complete deficiency in the production of globin chains, in most cases, α or β, which compose, together with the iron-containing porphyrins (hemes), the hemoglobin molecules in red blood cells (RBC). The major clinical sy...
Autor principal: | Fibach, Eitan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947291/ https://www.ncbi.nlm.nih.gov/pubmed/31810354 http://dx.doi.org/10.3390/jcm8122124 |
Ejemplares similares
-
Pathophysiology and treatment of patients with beta-thalassemia – an update
por: Fibach, Eitan, et al.
Publicado: (2017) -
Ineffective Erythropoiesis in β-Thalassemia
por: Ribeil, Jean-Antoine, et al.
Publicado: (2013) -
The Roles of Mitophagy and Autophagy in Ineffective Erythropoiesis in β-Thalassemia
por: Chaichompoo, Pornthip, et al.
Publicado: (2022) -
Challenging the Erythropoiesis Paradigm in β-Thalassemia
por: Vinchi, Francesca, et al.
Publicado: (2020) -
β-Thalassemia: HiJAKing Ineffective Erythropoiesis and Iron Overload
por: Melchiori, Luca, et al.
Publicado: (2010)